Anebulo Pharmaceuticals, Inc. Quarterly Assets in USD from Q2 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Anebulo Pharmaceuticals, Inc. quarterly Assets history and growth rate from Q2 2020 to Q3 2024.
Anebulo Pharmaceuticals, Inc. Assets for the quarter ending September 30, 2024 was $2.47M, a 72.7% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$2.47M	-$6.58M	-72.7%	Sep 30, 2024	10-Q	2024-11-13
Q2 2024	$4.07M	-$7.6M	-65.1%	Jun 30, 2024	10-Q	2024-11-13
Q1 2024	$6M	-$8.44M	-58.5%	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$7.5M	-$9.39M	-55.6%	Dec 31, 2023	10-Q	2024-02-13
Q3 2023	$9.05M	-$10.8M	-54.3%	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$11.7M	-$3.91M	-25.1%	Jun 30, 2023	10-K	2024-09-25
Q1 2023	$14.4M	-$2.82M	-16.3%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$16.9M	-$2.08M	-10.9%	Dec 31, 2022	10-Q	2023-02-10
Q3 2022	$19.8M	-$685K	-3.34%	Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$15.6M	-$6.07M	-28.1%	Jun 30, 2022	10-K	2023-09-22
Q1 2022	$17.2M	+$13M	+302%	Mar 31, 2022	10-Q	2022-05-11
Q4 2021	$19M			Dec 31, 2021	10-Q	2022-02-11
Q3 2021	$20.5M			Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$21.7M	+$18.6M	+615%	Jun 30, 2021	10-K	2022-09-09
Q1 2021	$4.29M			Mar 31, 2021	10-Q	2021-06-21
Q2 2020	$3.03M			Jun 30, 2020	10-K	2021-09-22

* An asterisk sign (*) next to the value indicates that the value is likely invalid.